Beta Bionics Partners with Senseonic on Diabetes Management Technology
1 report, 1 independent
Updated Sep 22
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Beta Bionics announced a partnership with Senseonic to integrate its automated insulin delivery systems with Senseonic’s Eversence 365 implantable sensor. The sensor is capable of measuring glucose levels for up to one year. The first integrated system is expected to launch commercially in the fourth quarter of this year.
From ocbj.com
Why it matters
The collaboration aims to expand the reach of the devices for individuals managing diabetes. The partnership follows the announcement, causing shares in Beta Bionics to rise 6.8% to $25.53, backed by a $1.2 billion market cap.
From ocbj.com